CareMax (NASDAQ:CMAX) reported quarterly earnings of $11.49 per share which beat the analyst consensus estimate of $(8.70) by 232.07 percent. The company reported quarterly sales of $232.200 million which beat the analyst consensus estimate of $197.239 million by 17.72 percent. This is a 34.23 percent increase over sales of $172.983 million the same period last year.
CareMax Q1 2024 GAAP EPS $11.49 Beats $(8.70) Estimate, Sales $232.200M Beat $197.239M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.